enGene Therapeutics Inc. Share Price
ENGN$1.71
+$0.11 (6.87%) Last updated on 21 May, 2026 | 23:32 ISTenGene Therapeutics Inc. Stock Performance
Open $1.61 | Prev. Close $1.60 | Circuit Range N/A |
Day Range $1.61 - $1.72 | Year Range $1.41 - $12.25 | Volume 52,898 |
Average Traded $1.65 |
enGene Therapeutics Inc. Share Price Chart
$1.71
Please wait...
About enGene Therapeutics Inc.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada.
enGene Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
19-May-26 | $1.53 | $1.53 | -2.23% |
18-May-26 | $1.71 | $1.57 | -9.51% |
15-May-26 | $1.73 | $1.74 | -3.88% |
14-May-26 | $1.56 | $1.80 | +17.21% |
13-May-26 | $1.46 | $1.54 | +6.57% |
12-May-26 | $1.47 | $1.45 | -2.36% |
11-May-26 | $1.50 | $1.48 | +0.34% |
FAQs on enGene Therapeutics Inc. Share Price
Can I buy enGene Therapeutics Inc. shares in India?
Yes. You can buy enGene Therapeutics Inc. in India by opening an international trading account.
What is the share price of enGene Therapeutics Inc.?
As on 21 May '26, the share price of enGene Therapeutics Inc. ENGN is $1.71. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of enGene Therapeutics Inc.?
The 5 year returns of enGene Therapeutics Inc. is -82.73% as on 21 May '26.
What are the high & low stock price of enGene Therapeutics Inc. today?
enGene Therapeutics Inc. stock price hit a high of $1.72 and low of $1.61 as on 21 May '26.
What is the 52-week high and low of enGene Therapeutics Inc. stock?
The 52-week high of enGene Therapeutics Inc. stock is $12.25, while the 52-week low is $1.41 as on 21 May '26.